Ventas, Inc. (VTR) Reports Strong 2025 Growth, Accelerates Senior Housing Investments

Ventas, Inc. (NYSE:VTR) is one of Goldman Sachs’ top REIT stock picks. On February 5, Ventas, Inc. (NYSE:VTR) reported its full-year and fourth-quarter 2025 results, highlighting strong growth across its senior housing portfolio.

CEO Debra Cafaro noted that Same-Store Cash NOI in the Senior Housing Operating Portfolio (SHOP) rose by more than 15% for the year, driven by U.S. occupancy gains and higher revenue per occupied room. The company completed $2.5 billion in senior housing investments during 2025 and raised $3.2 billion in equity, maintaining a strong balance sheet with $5.3 billion in liquidity and a Net Debt-to-Adjusted EBITDA ratio of 5.2x.

Fourth-quarter results showed net income of $0.15 per share and normalized FFO of $0.89 per share, up roughly 10% from the prior year. SHOP Same-Store Cash NOI grew over 15%, led by 18% growth in the U.S., supported by rising occupancy and RevPOR. Full-year results included net income of $0.54 per share, normalized FFO of $3.48, and total company NOI growth of 16%, reinforcing Ventas’ strategy of driving both organic growth and accretive external investments. The company also declared a quarterly dividend of $0.52 per share, an 8% increase.

Looking ahead to 2026, Ventas expects continued SHOP segment growth and plans approximately $2.5 billion in senior housing investments. Full-year guidance projects net income of $0.57 per share and normalized FFO of $3.83, an 8% increase on a comparable basis. The company also updated its FFO calculation methodology to exclude non-cash stock-based compensation, aligning with industry peers and its financial covenant metrics. Early 2026 activity already includes over $0.8 billion in senior housing acquisitions, reflecting strong pipeline momentum.

Ventas, Inc. (NYSE:VTR) is a leading S&P 500 real estate investment trust (REIT) that owns and manages a diverse portfolio of over 1,200-1,400 healthcare and senior living properties across the United States, Canada, and the United Kingdom. The company focuses on investing in senior housing, medical office buildings, and research/innovation centers to support the aging population.

While we acknowledge the potential of VTR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 14 Best NYSE Penny Stocks to Buy Now and 10 Best 52-Week Low Blue Chip Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.